# Merryspring Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/merryspring-medical

- Industry: Medical Devices & Equipment
- Headquarters: Jiaxing, China
- Total disclosed funding: $14M
- Latest round: Series B (Nov 18, 2025)
- Investors on record: 2

## About

Founded in 2022 and based in Jiaxing, China, Ronghe Medical Technology (Zhejiang) Co., Ltd. develops medical devices that apply energy-based ablation technologies for respiratory diseases and oncology. The company focuses on device platforms that integrate electromagnetic navigation and non-thermal ablation mechanisms to support minimally invasive interventions. In November 2025, the company closed a round of series B funding led by Qiming Venture Partners.

The company works with hospitals and clinical research institutions to provide energy-based ablation platforms such as the "Breeze One" electromagnetic-navigation pulsed-field ablation system. Its solutions support targeted airway intervention, real-time guidance and automated ablation mapping for COPD and other respiratory disease management.

The company generates revenue through direct sales of medical devices to hospitals and clinical partners.

The company plans to expand clinical adoption of its COPD intervention system, pursue additional domestic and international regulatory approvals and advance global commercialization of its respiratory ablation product line.

## Funding rounds

- Series B, Nov 18, 2025, $14M — Qiming Venture Partners, Lotus Lake Capital

## Investors

- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series B
- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Series B